Aung Shoon Lae, Sengupta Aditya, Win Nwe Ni, Rajkanna Jeyanthy, Oyibo Samson O
General Medicine, Peterborough City Hospital, Peterborough, GBR.
Internal Medicine, Peterborough City Hospital, Peterborough, GBR.
Cureus. 2025 Jan 5;17(1):e76954. doi: 10.7759/cureus.76954. eCollection 2025 Jan.
Background Peripheral intravenous cannula (PIVC) insertion is a universal intervention for hospital inpatients. Previous studies have demonstrated that more than a third of inserted PIVCs remain unused in the emergency department and that there is inadequate documentation regarding the insertion and use of PIVCs. Additionally, the use of PIVC is associated with cannula-related complications. Using the PIVC care bundle attached to the guideline should help prevent cannula-related complications. As part of a quality improvement project, we aimed to perform an initial audit (1 cycle), implement interventions for improvements, and then perform a re-audit (2 cycle) of our adherence with the use and completion of the care bundle for PIVC. Methodology An initial audit (1 cycle), followed by implementation of interventions, and then a re-audit (2 cycle) of our adherence with the use and completion of the PIVC care bundle was performed. The standards/criteria used for both the 1 cycle and 2 cycle of the project were obtained from our PIVC care bundle and comprised of documented evidence of the date of cannula insertion, site of cannula insertion, indication for cannula insertion, whether the cannula was inserted in a non-common site (e.g., lower limbs), cannula assessment at least every 24 hours, cannula-related complications, and whether the cannula care bundle was completed for the patient. A score of less than 75% was considered not adherent, 75-90% was partially adherent, 90-100% was adherent, and a score of 100% was considered fully adherent. The target adherence score for each standard/criterion was set a priori to 90-100%, and the results were compared between both cycles. An increase in the adherence score in the 2 cycle over the 1 cycle was taken to indicate improvement, while a negative difference indicated challenges. Results There were 28 patients in the 1 cycle and 40 patients in the 2 cycle of this project. The commonest initial indications for PIVC insertion were intravenous fluids and intravenous antibiotic administration. The hand and forearm were the commonly used sites of insertion, and none of the patients had a cannula-related complication. Compared to the 1 cycle, the results of the 2 cycle demonstrated improvements in the adherence scores for all the standards/criteria, with the scores for documenting the site of insertion and using a commonly used/acceptable site indicating full adherence (100%). The score for documenting the indication for insertion indicated adherence (90-100%). The score for ensuring that the cannula was being assessed at least every 24 hours and the score for completing the care bundle both indicated partial adherence (75-90%). The score for documenting the date of cannula insertion indicated non-adherence (<75%). Conclusions This project has demonstrated improvement in adherence with the use and completion of the care bundle for PIVC insertion after implementing interventions for improvement. National guidance is required to produce a standard audit tool for general use. The importance of continued education, complete cannula care, and accurate documentation in enhancing adherence to consensus guidelines cannot be overemphasized.
背景 外周静脉留置针(PIVC)穿刺是医院住院患者普遍接受的一项干预措施。既往研究表明,在急诊科,超过三分之一的已穿刺PIVC未被使用,且关于PIVC穿刺和使用的记录不充分。此外,PIVC的使用与留置针相关并发症有关。采用指南所附的PIVC护理集束应有助于预防留置针相关并发症。作为质量改进项目的一部分,我们旨在进行一次初始审核(第1周期),实施改进干预措施,然后对我们使用和完成PIVC护理集束的情况进行重新审核(第2周期)。
方法 我们进行了一次初始审核(第1周期),随后实施干预措施,然后对我们使用和完成PIVC护理集束的情况进行重新审核(第2周期)。该项目第1周期和第2周期使用的标准/准则均来自我们的PIVC护理集束,包括留置针穿刺日期、穿刺部位、穿刺指征、留置针是否在非常用部位(如下肢)穿刺、至少每24小时进行一次留置针评估、留置针相关并发症以及是否为患者完成了留置针护理集束的书面证据。得分低于75%被视为不依从,75 - 90%为部分依从,90 - 100%为依从,100%的得分被视为完全依从。每个标准/准则的目标依从得分预先设定为90 - 100%,并对两个周期的结果进行比较。第2周期依从得分相对于第1周期有所增加表明有改进,而负差异则表明存在挑战。
结果 本项目第1周期有28例患者,第2周期有40例患者。PIVC穿刺最常见的初始指征是静脉输液和静脉给予抗生素。手部和前臂是常用的穿刺部位,且所有患者均未发生留置针相关并发症。与第1周期相比,第2周期的结果显示所有标准/准则的依从得分均有提高,其中记录穿刺部位和使用常用/可接受部位的得分表明完全依从(100%)。记录穿刺指征的得分表明依从(90 - 100%)。确保至少每24小时对留置针进行一次评估的得分以及完成护理集束的得分均表明部分依从(75 - 90%)。记录留置针穿刺日期的得分表明不依从(<75%)。
结论 本项目表明,在实施改进干预措施后,PIVC穿刺护理集束的使用和完成的依从性有所提高。需要国家指南来制定通用的标准审核工具。持续教育、完整的留置针护理以及准确的记录对于提高对共识指南的依从性的重要性再怎么强调也不为过。